Log on / register
Feedback | Support | My details
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.
Vitale C, Mercuro G, Castiglioni C, Cornoldi A, Tulli A, Fini M, Volterrani M, Rosano GM
Cardiovasc Diabetol 2005 May 15, 4:6
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Original investigation    
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients
Kintscher U, Bramlage P, Paar WD, Thoenes M, Unger T
Cardiovascular Diabetology 2007, 6:12 (3 April 2007)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.